Related Experiment Video
Updated: Jan 21, 2026

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
Published on: October 13, 2022
Molecular Modeling of ALK L1198F and/or G1202R Mutations to Determine Differential Crizotinib Sensitivity
Yu-Chung Chuang1, Bo-Yen Huang1, Hsin-Wen Chang1
1Department of Life Sciences, National University of Kaohsiung, Kaohsiung, Taiwan.
Abstract:
Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that has been recognized as a therapeutic target for EML4-ALK fusion-positive nonsmall cell lung cancer (NSCLC) treatment using type I kinase inhibitors such as crizotinib to take over the ATP binding site. According to Shaw's measurements, ALK carrying G1202R mutation shows reduced response to crizotinib (IC50 = 382 nM vs. IC50 = 20 nM for wild-type), whereas L1198F mutant is more responsive (IC50 = 0.4 nM). Interestingly, the double mutant L1198F/G1202R maintains a similar response (IC50 = 31 nM) to the wild-type. Herein we conducted molecular modeling simulations to elucidate the varied crizotinib sensitivities in three mutants carrying L1198F and/or G1202R. Both L1198 and G1202 are near the ATP pocket. Mutation G1202R causes steric hindrance that blocks crizotinib accessibility, which greatly reduces efficacy, whereas mutation L1198F enlarges the binding pocket entrance and hydrophobically interacts with crizotinib to enhance sensitivity. With respect to the double mutant L1198F/G1202R, F1198 indirectly pulls R1202 away from the binding entrance and consequently alleviates the steric obstacle introduced by R1202. These results demonstrated how the mutated residues tune the crizotinib response and may assist kinase inhibitor development especially for ALK G1202R, analogous to the ROS1 G2302R and MET G1163R mutations that are also resistant to crizotinib treatment in NSCLC.
Insights
Anaplastic lymphoma kinase (ALK) mutations affect crizotinib response in non-small cell lung cancer. Molecular modeling reveals G1202R mutation hinders drug binding, while L1198F enhances it, guiding future kinase inhibitor development.
Area of Science:
- Molecular biology
- Pharmacology
- Computational chemistry
Background:
- Anaplastic lymphoma kinase (ALK) is a key therapeutic target in non-small cell lung cancer (NSCLC).
- Crizotinib, a type I kinase inhibitor, targets the ATP binding site of ALK.
- Specific ALK mutations, such as G1202R and L1198F, influence crizotinib sensitivity.
Purpose of the Study:
- To elucidate the molecular mechanisms behind varied crizotinib sensitivities in ALK mutants.
- To investigate the impact of G1202R and L1198F mutations on crizotinib binding.
- To provide insights for developing improved kinase inhibitors for NSCLC treatment.
Main Methods:
- Conducted molecular modeling simulations.
- Analyzed the structural interactions between crizotinib and wild-type/mutant ALK proteins.
- Correlated structural findings with experimental drug response data (IC50 values).
Main Results:
- The ALK G1202R mutation causes steric hindrance, reducing crizotinib accessibility and efficacy.
- The ALK L1198F mutation enlarges the binding pocket entrance and enhances crizotinib sensitivity through hydrophobic interactions.
- The double mutant L1198F/G1202R shows alleviated steric hindrance, maintaining similar response to wild-type ALK.
Conclusions:
- Mutated residues near the ATP pocket significantly tune crizotinib response in ALK.
- Understanding these structural-functional relationships can guide the design of next-generation ALK inhibitors.
- Findings are relevant for overcoming crizotinib resistance in NSCLC, similar to resistance mechanisms in ROS1 and MET.
More Related Videos
06:39Differentiation, Maintenance, and Analysis of Human Retinal Pigment Epithelium Cells: A Disease-in-a-dish Model for BEST1 Mutations
Published on: August 24, 2018
15:05Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Related Concept Videos
Molecular Models
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Viral Mutations
Mutation, Gene Flow, and Genetic Drift